Summary : The Pfizer COVID-19 vaccine provides less immunity against Omicron than from other coronavirus variants, according to a lab study that…
DNA
-
-
IndiaPharma Science & Research
The NTAGI is Considering Giving Immunocompromised Persons a “Additional” Dosage of COVID-19 Vaccination.
by adminby adminSynopsis: A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is…
-
CompaniesPfizerPharma Science & ResearchTGA
TGA Provisionally Approves Pfizer Vaccine for Children aged 5-11 yrs
by adminby adminSynopsis: The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…
-
CompaniesPfizer
Pfizer/Covid BioNTech’s vaccine for younger children has been moved up to December 13 by the European Union.
by adminby adminThe European Union-wide rollout of Pfizer and BioNTech’s Covid-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…
-
Synopsis : Zydus Cadila’s COVID-19 vaccine ZyCoV-D will be initially introduced in seven States including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar…
-
IndiaPharma Science & Research
Govt to get 1 Crore Covid Vaccine Dose From Zydus Cadila at Rs 265/Dose
by adminby adminDrug firm Zydus Cadila on Monday said it has received an order to supply one crore doses of its Covid-19 vaccine, ZyCoV-D,…
-
Agrochemicals
IMPACT Therapeutics Announced ATR Inhibitor IMP9064 IND Clearance by USFDA.
by adminby adminSUMMARY: Impact Therapeutics is a biopharmaceutical company, announced that its ATR inhibitor IMP9064 has received the IND clearance from the US Food…